Dr. Heda Hosseini is a translational scientist specializing in cancer metastasis and precision oncology. His research integrates biomarker discovery, disease modeling, and the development of clinically relevant applications aimed at improving cancer diagnosis and treatment.
He earned his doctorate in Biomedicine from the University of Regensburg, where he developed a strong foundation in tumor biology. Following his doctoral studies, Dr. Hosseini focused on investigating tumorigenesis, metastatic progression, and innovative therapeutic strategies.
Dr. Hosseini’s work leverages advanced technologies such as next-generation sequencing, single-cell analysis, and computational modeling to identify predictive biomarkers that can enhance the efficacy of cancer therapies. His multidisciplinary approach bridges laboratory research and clinical translation, positioning his work at the forefront of precision medicine.
He has established a strong international presence through an extensive publication record, as well as successful collaborations and competitively awarded research funding. His contributions have had a significant impact on advancing the understanding of cancer biology and therapeutic development.
Currently, Dr. Hosseini’s research focuses on uncovering the mechanisms by which disseminated cancer cells evade immune surveillance and targeted therapies. His goal is to develop strategies that improve existing treatment regimens and to design novel therapeutic approaches capable of intercepting metastasis at its earliest stages.